The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Biological Indicators-Global Market Insights and Sales Trends 2025
Synopsis
Biological indicators (BIs), as defined by ANSI/AAMI and ISO, are test systems containing viable microorganisms providing a defined resistance to a specific sterilization process. A biological indicator provides information on whether necessary conditions were met to kill a specified number of microorganisms for a given sterilization process, providing a level of confidence in the process.
The global Biological Indicators market size is expected to reach US$ 550.2 million by 2029, growing at a CAGR of 5.9% from 2023 to 2029. The market is mainly driven by the significant applications of Biological Indicators in various end use industries. The expanding demands from the Hospital, Pharma Companies and Others,, are propelling Biological Indicators market. Self-Contained Biological Indicator, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Biological Indicator Strip segment is estimated at % CAGR for the next seven-year period.
Global Biological Indicators main players are 3M, Getinge Group, Cantel Medical, Mesa Laboratories, Steris, etc. Global top five manufacturers hold a share over 65%. North America is the largest market, with a share nearly 55%.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Biological Indicators, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Biological Indicators market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Biological Indicators market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Biological Indicators sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Biological Indicators covered in this report include 3M, Getinge Group, Cantel Medical, Mesa Laboratories, Steris, Fuze Medical, Matachana, Hu-Friedy and Advanced Sterilization, etc.
The global Biological Indicators market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
3M
Getinge Group
Cantel Medical
Mesa Laboratories
Steris
Fuze Medical
Matachana
Hu-Friedy
Advanced Sterilization
Bag Health Care
Terragene
Andersen
GKE
Global Biological Indicators market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Biological Indicators market, Segment by Type:
Self-Contained Biological Indicator
Biological Indicator Strip
Global Biological Indicators market, by Application
Hospital
Pharma Companies
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Biological Indicators companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Biological indicators (BIs), as defined by ANSI/AAMI and ISO, are test systems containing viable microorganisms providing a defined resistance to a specific sterilization process. A biological indicator provides information on whether necessary conditions were met to kill a specified number of microorganisms for a given sterilization process, providing a level of confidence in the process.
The global Biological Indicators market size is expected to reach US$ 550.2 million by 2029, growing at a CAGR of 5.9% from 2023 to 2029. The market is mainly driven by the significant applications of Biological Indicators in various end use industries. The expanding demands from the Hospital, Pharma Companies and Others,, are propelling Biological Indicators market. Self-Contained Biological Indicator, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Biological Indicator Strip segment is estimated at % CAGR for the next seven-year period.
Global Biological Indicators main players are 3M, Getinge Group, Cantel Medical, Mesa Laboratories, Steris, etc. Global top five manufacturers hold a share over 65%. North America is the largest market, with a share nearly 55%.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Biological Indicators, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Biological Indicators market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Biological Indicators market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Biological Indicators sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Biological Indicators covered in this report include 3M, Getinge Group, Cantel Medical, Mesa Laboratories, Steris, Fuze Medical, Matachana, Hu-Friedy and Advanced Sterilization, etc.
The global Biological Indicators market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
3M
Getinge Group
Cantel Medical
Mesa Laboratories
Steris
Fuze Medical
Matachana
Hu-Friedy
Advanced Sterilization
Bag Health Care
Terragene
Andersen
GKE
Global Biological Indicators market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Biological Indicators market, Segment by Type:
Self-Contained Biological Indicator
Biological Indicator Strip
Global Biological Indicators market, by Application
Hospital
Pharma Companies
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Biological Indicators companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Biological Indicators
1.1 Biological Indicators Market Overview
1.1.1 Biological Indicators Product Scope
1.1.2 Biological Indicators Market Status and Outlook
1.2 Global Biological Indicators Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Biological Indicators Market Size by Region (2018-2029)
1.4 Global Biological Indicators Historic Market Size by Region (2018-2023)
1.5 Global Biological Indicators Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Biological Indicators Market Size (2018-2029)
1.6.1 North America Biological Indicators Market Size (2018-2029)
1.6.2 Europe Biological Indicators Market Size (2018-2029)
1.6.3 Asia-Pacific Biological Indicators Market Size (2018-2029)
1.6.4 Latin America Biological Indicators Market Size (2018-2029)
1.6.5 Middle East & Africa Biological Indicators Market Size (2018-2029)
2 Biological Indicators Market by Type
2.1 Introduction
2.1.1 Self-Contained Biological Indicator
2.1.2 Biological Indicator Strip
2.2 Global Biological Indicators Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Biological Indicators Historic Market Size by Type (2018-2023)
2.2.2 Global Biological Indicators Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Biological Indicators Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Biological Indicators Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Biological Indicators Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Biological Indicators Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Biological Indicators Revenue Breakdown by Type (2018-2029)
3 Biological Indicators Market Overview by Application
3.1 Introduction
3.1.1 Hospital
3.1.2 Pharma Companies
3.1.3 Others
3.2 Global Biological Indicators Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Biological Indicators Historic Market Size by Application (2018-2023)
3.2.2 Global Biological Indicators Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Biological Indicators Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Biological Indicators Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Biological Indicators Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Biological Indicators Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Biological Indicators Revenue Breakdown by Application (2018-2029)
4 Biological Indicators Competition Analysis by Players
4.1 Global Biological Indicators Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Biological Indicators as of 2022)
4.3 Date of Key Players Enter into Biological Indicators Market
4.4 Global Top Players Biological Indicators Headquarters and Area Served
4.5 Key Players Biological Indicators Product Solution and Service
4.6 Competitive Status
4.6.1 Biological Indicators Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 3M
5.1.1 3M Profile
5.1.2 3M Main Business
5.1.3 3M Biological Indicators Products, Services and Solutions
5.1.4 3M Biological Indicators Revenue (US$ Million) & (2018-2023)
5.1.5 3M Recent Developments
5.2 Getinge Group
5.2.1 Getinge Group Profile
5.2.2 Getinge Group Main Business
5.2.3 Getinge Group Biological Indicators Products, Services and Solutions
5.2.4 Getinge Group Biological Indicators Revenue (US$ Million) & (2018-2023)
5.2.5 Getinge Group Recent Developments
5.3 Cantel Medical
5.3.1 Cantel Medical Profile
5.3.2 Cantel Medical Main Business
5.3.3 Cantel Medical Biological Indicators Products, Services and Solutions
5.3.4 Cantel Medical Biological Indicators Revenue (US$ Million) & (2018-2023)
5.3.5 Mesa Laboratories Recent Developments
5.4 Mesa Laboratories
5.4.1 Mesa Laboratories Profile
5.4.2 Mesa Laboratories Main Business
5.4.3 Mesa Laboratories Biological Indicators Products, Services and Solutions
5.4.4 Mesa Laboratories Biological Indicators Revenue (US$ Million) & (2018-2023)
5.4.5 Mesa Laboratories Recent Developments
5.5 Steris
5.5.1 Steris Profile
5.5.2 Steris Main Business
5.5.3 Steris Biological Indicators Products, Services and Solutions
5.5.4 Steris Biological Indicators Revenue (US$ Million) & (2018-2023)
5.5.5 Steris Recent Developments
5.6 Fuze Medical
5.6.1 Fuze Medical Profile
5.6.2 Fuze Medical Main Business
5.6.3 Fuze Medical Biological Indicators Products, Services and Solutions
5.6.4 Fuze Medical Biological Indicators Revenue (US$ Million) & (2018-2023)
5.6.5 Fuze Medical Recent Developments
5.7 Matachana
5.7.1 Matachana Profile
5.7.2 Matachana Main Business
5.7.3 Matachana Biological Indicators Products, Services and Solutions
5.7.4 Matachana Biological Indicators Revenue (US$ Million) & (2018-2023)
5.7.5 Matachana Recent Developments
5.8 Hu-Friedy
5.8.1 Hu-Friedy Profile
5.8.2 Hu-Friedy Main Business
5.8.3 Hu-Friedy Biological Indicators Products, Services and Solutions
5.8.4 Hu-Friedy Biological Indicators Revenue (US$ Million) & (2018-2023)
5.8.5 Hu-Friedy Recent Developments
5.9 Advanced Sterilization
5.9.1 Advanced Sterilization Profile
5.9.2 Advanced Sterilization Main Business
5.9.3 Advanced Sterilization Biological Indicators Products, Services and Solutions
5.9.4 Advanced Sterilization Biological Indicators Revenue (US$ Million) & (2018-2023)
5.9.5 Advanced Sterilization Recent Developments
5.10 Bag Health Care
5.10.1 Bag Health Care Profile
5.10.2 Bag Health Care Main Business
5.10.3 Bag Health Care Biological Indicators Products, Services and Solutions
5.10.4 Bag Health Care Biological Indicators Revenue (US$ Million) & (2018-2023)
5.10.5 Bag Health Care Recent Developments
5.11 Terragene
5.11.1 Terragene Profile
5.11.2 Terragene Main Business
5.11.3 Terragene Biological Indicators Products, Services and Solutions
5.11.4 Terragene Biological Indicators Revenue (US$ Million) & (2018-2023)
5.11.5 Terragene Recent Developments
5.12 Andersen
5.12.1 Andersen Profile
5.12.2 Andersen Main Business
5.12.3 Andersen Biological Indicators Products, Services and Solutions
5.12.4 Andersen Biological Indicators Revenue (US$ Million) & (2018-2023)
5.12.5 Andersen Recent Developments
5.13 GKE
5.13.1 GKE Profile
5.13.2 GKE Main Business
5.13.3 GKE Biological Indicators Products, Services and Solutions
5.13.4 GKE Biological Indicators Revenue (US$ Million) & (2018-2023)
5.13.5 GKE Recent Developments
6 North America
6.1 North America Biological Indicators Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Biological Indicators Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Biological Indicators Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Biological Indicators Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Biological Indicators Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Biological Indicators Market Dynamics
11.1 Biological Indicators Industry Trends
11.2 Biological Indicators Market Drivers
11.3 Biological Indicators Market Challenges
11.4 Biological Indicators Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
